Your Location:Home >Products >API >1103522-45-7

1103522-45-7

  • Product Name:ACT-132577 (Aprocitentan)
  • Molecular Formula:C16H14Br2N6O4S
  • Molecular Weight:546.199
Inquiry

Product Details

Purity:99%

Cost-effective and customizable ACT-132577 (Aprocitentan) 1103522-45-7 supplier

  • Molecular Formula:C16H14Br2N6O4S
  • Molecular Weight:546.199
  • Boiling Point:705.0±70.0 °C(Predicted) 
  • PKA:13.56±0.60(Predicted) 
  • PSA:150.59000 
  • Density:1.841±0.06 g/cm3(Predicted) 
  • LogP:4.38590 

1103522-45-7 Relevant articles

CRYSTALLINE FORMS OF A 4-PYRIMIDINESULFAMIDE DERIVATIVE APROCITENTAN

-

Paragraph 0231, (2020/01/22)

The present invention concerns novel cry...

COMBINATION OF A 4-PYRIMIDINESULFAMIDE DERIVATIVE WITH AN SGLT-2 INHIBITOR FOR THE TREATMENT OF ENDOTHELIN RELATED DISEASES

-

Page/Page column 38, (2019/06/17)

The present invention concerns the compo...

PROCESS FOR MANUFACTURING PYRIMIDINE SULFAMIDE DERIVATIVES

-

Page/Page column 45, (2015/09/22)

The invention relates to a process for m...

The discovery of N -[5-(4-bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy] ethoxy]-4-pyrimidinyl]- N ′-propylsulfamide (macitentan), an orally active, potent dual endothelin receptor antagonist

Bolli, Martin H.,Boss, Christoph,Binkert, Christoph,Buchmann, Stephan,Bur, Daniel,Hess, Patrick,Iglarz, Marc,Meyer, Solange,Rein, Josiane,Rey, Markus,Treiber, Alexander,Clozel, Martine,Fischli, Walter,Weller, Thomas

, p. 7849 - 7861 (2012/10/29)

Starting from the structure of bosentan ...

1103522-45-7 Process route

5-(4-bromophenyl)-4-(2-((5-bromopyrimidin-2-yl)oxy)ethoxy)-6-fluoropyrimidine

5-(4-bromophenyl)-4-(2-((5-bromopyrimidin-2-yl)oxy)ethoxy)-6-fluoropyrimidine

ACT-132577
1103522-45-7

ACT-132577

Conditions
Conditions Yield
With potassium carbonate; SULFAMIDE; In dimethyl sulfoxide; at 70 ℃; for 3h; Solvent;
84%
With potassium carbonate; SULFAMIDE; In water; dimethyl sulfoxide; at 70 - 75 ℃; for 4h; Time; Temperature;
77%
With potassium carbonate; SULFAMIDE; In dimethyl sulfoxide; at 70 ℃; for 3h; Reagent/catalyst;
65%
5-(4-bromophenyl)-4-(2-((5-bromopyrimidin-2-yl)oxy)ethoxy)-6-chloropyrimidine

5-(4-bromophenyl)-4-(2-((5-bromopyrimidin-2-yl)oxy)ethoxy)-6-chloropyrimidine

ACT-132577
1103522-45-7

ACT-132577

Conditions
Conditions Yield
5-(4-bromophenyl)-4-(2-((5-bromopyrimidin-2-yl)oxy)ethoxy)-6-chloropyrimidine; With cesium fluoride; In dimethyl sulfoxide; at 70 ℃; for 2.5h;
With potassium carbonate; SULFAMIDE; In dimethyl sulfoxide; for 3h; Reagent/catalyst; Heating;
77%

1103522-45-7 Upstream products

  • 441796-09-4
    441796-09-4

    benzylsulfamic acid {5-(4-bromophenyl)-6-[2-(5-bromopyrimidin-2-yloxy)-ethoxy]-pyrimidine-4-yl}-amide

  • 41841-16-1
    41841-16-1

    (4-bromo-phenyl)-acetic acid methyl ester

  • 1878-68-8
    1878-68-8

    2-(4-bromophenyl)-acetic acid

  • 146533-41-7
    146533-41-7

    5-(4-bromophenyl)-4,6-dichloropyrimidine

Relevant Products